Beijing-based Haoyundao Information Technology, operator of mobile medical laboratory results analysis app "Paiyipai," has announced that the company has completed RMB 8-digit Series A+ funding from undisclosed sources. After this round of funding, the company will officially change the name of its platform to Medp.AI, adopt a new domain name, and begin using a new logo.
Medp.AI is based on artificial intelligence technology, and integrates large volumes of medical data to research and develop medical imaging diagnosis and identification systems. The company's medical imaging smart research focuses primarily on CT, MRI, PET, pathological specimen sections, ultrasound, and other medical imaging information collection and analysis.
Currently, Medp.AI has accumulated 100 mln counts of medical data processing experience while providing deep learning vertical solutions for over 400 hospitals, insurance companies, dialysis centers, private hospitals, and medical equipment manufacturers.
Editor's Note: For more information on this topic, please see "Medical Laboratory Results Analysis App Paiyipai Wins RMB 30 Mln Series A," MD 1/25/16 issue.